CD244 modulates bone marrow infiltrating CD8+ T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia

A specific immune marker on leukemia-infiltrating cells may help predict outcomes and identify new immunotherapy targets in AML.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.